Drawing for Serial No. 79408867

USPTO serial 79408867

Serial No. 79408867

Reviewed by CopyMark Law Group

Reg. 7963149Status 700Registered
Filing date
Status date
Registration date
Sep 30, 2025
Examiner
MILMOE, MAUREEN H
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79408867?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Minchul Yang

Minchul Yang STIP Law Group, LLC40 W. Chesapeake Ave, Suite 506Towson, MD 21204United States

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic reagents for scientific use; Reagents for scientific purposes for use in nucleic acid amplifications; Markers being reagents for scientific purposes for use in analyzing nucleic acid; Reagents for scientific purposes for use in extracting nucleic acid; Chemical reagents for use in nucleic acid amplifications, other than for medical or veterinary purposes; Chemical reagents for use in extracting nucleic acid, other than for medical or veterinary purposes; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Diagnostic reagents for scientific or research use; Reagents for scientific useACTIVE—
005Reagents for medical use; Drugs for medical purposes, namely, acetaminophen; Enzymes for medical purposes; Enzyme preparations for medical purposes; Nucleic acid sequences for medical and veterinary purposes; Diagnostic chemical preparations for medical purposes for use in DNA analysis; In vitro diagnostic preparations for medical purposes; Diagnostic test reagents for medical or veterinary purposes; Chemical reagents for medical or veterinary purposes; Reagents for use in medical genetic testingACTIVE—
009Diagnostic apparatus for research laboratory use for DNA analysis; Laboratory devices for DNA sequencing, not for medical purposes; Laboratory devices for analyzing polynucleic acid, not for medical purposes; Reagent containers being chips having multi-well arrays for use with protein analysis apparatus used in chemical analysis and biological analysis for laboratory research use; Laboratory devices for analyzing and extracting genes, not for medical purposes; Laboratory apparatus and instruments for preparing nucleic acid samples; Diagnostic chips being bio-chips for analyzing blood plasma for laboratory use; Laboratory apparatus, namely, devices for analyzing protein sequences, not for medical purposes; Scientific apparatus, namely, diagnostic apparatus for research laboratory use for analyzing genesACTIVE—
035Wholesale store services featuring chemicals for analyzing nucleic acid for scientific or laboratory purposes; Computerized database management; Retail store services featuring medical apparatus and instruments other than for dental purposes; Retail store services featuring chemicals for analyzing nucleic acid for scientific or laboratory purposes; Wholesale store services featuring pharmaceutical products for humans and animals; Retail store services featuring pharmaceutical products for humans and animals; Wholesale store services featuring chemical preparations for use in industry; Retail store services featuring chemical preparations for use in industryACTIVE—
042Biomarker discovery services being medical research; Medical diagnostic services using biomarker analysis; Selection and screening of biomarkers in biological tissue samples for scientific research purposes; Scientific research for medical purposes in the area of cancerous diseases; Consulting business, namely, consulting services in the field of biological sequence processing and analysis for medical research purposes; Research in the field of gene expression analysis; Development of computer software for use with medical equipment; Providing computer software technical support services, namely, troubleshooting of computer software problems in the field of medical diagnostics; Product development in the field of medical diagnostic devices; Blood testing business, namely, blood testing for medical research purposesACTIVE—
044Medical analysis for the diagnosis and treatment of persons; Medical laboratory analysis services relating to the treatment of persons; Medical services relating to the removal, treatment and processing of human blood; RNA or DNA analysis being medical analysis services for the diagnosis of cancer; Medical analysis services for the diagnosis of cancer; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Provision of genetic testing for medical purposes; Provision of information for medical purposes in the field of gene therapy for cancer treatment; Medical diagnostic services; medical screening; Genetic counselingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 30, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 23, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 16, 2026LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Apr 9, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 9, 2026FIMPFINAL DISPOSITION PROCESSED—
Apr 6, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 6, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 30, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 30, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 30, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 12, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 12, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 6, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 5, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 5, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Jul 5, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 5, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 5, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 1, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 1, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 1, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 17, 2025RFNTREFUSAL PROCESSED BY IB—
Jan 2, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 2, 2025RFRRREFUSAL PROCESSED BY MPU—
Dec 14, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 13, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 10, 2024DOCKASSIGNED TO EXAMINER—
Nov 8, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 8, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 7, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance